Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.
An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results